Diggal Pharma Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 5.00 M
- Company Age 3 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.00 M
- Revenue Growth 329.72%
- Profit Growth 74.57%
- Ebitda 31.19%
- Net Worth -7.92%
- Total Assets 19.45%
About Diggal Pharma
Diggal Pharma Private Limited (DPPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 September 2021 (Three years and four months 20 days old ). Its registered office is in Meerut, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹4.00 M.
Gajendra Singh, Anita Singh, Dinesh Kumar, and Two other members serve as directors at the Company.
Company Details
- Location
Meerut, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U51909UP2021PTC152064
- Company No.
152064
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Sep 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Diggal Pharma?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Verma  | Director | 12-Sep-2021 | Current |
| Gajendra Singh | Director | 12-Sep-2021 | Current |
| Anita Singh | Director | 12-Sep-2021 | Current |
| Dinesh Kumar | Director | 12-Sep-2021 | Current |
| Rashmi | Director | 12-Sep-2021 | Current |
Financial Performance of Diggal Pharma.
Diggal Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 329.72% increase. The company also saw a substantial improvement in profitability, with a 74.57% increase in profit. The company's net worth dipped by a decrease of 7.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Diggal Pharma?
Unlock access to Diggal Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Gda Healthcare Private LimitedGajendra Singh, Dinesh Kumar and 1 more are mutual person
- Lucrose Agro Private Limited
Gajendra Singh, Dinesh Kumar and 1 more are mutual person
- Lucrose Pharma Private Limited
Gajendra Singh, Anita Singh and 2 more are mutual person
Charges (Loans)
₹4.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.40 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jul 2022 | Others | ₹4.00 M | Open |
How Many Employees Work at Diggal Pharma?
Diggal Pharma has a workforce of 98 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Diggal Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Diggal Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.